Literature DB >> 25943315

Epigenetic mechanisms in the pathophysiology of psychotic disorders.

W Brad Ruzicka1.   

Abstract

Epigenetics is the study of chromatin-the physical material that forms chromosomes, composed of DNA wound around specialized histone proteins-and of how the modification of chromatin acts to establish stable states of gene expression in a cell-specific manner. Chromatin is regulated through three mechanisms: DNA methylation, histone modification, and RNA interference. These basic biological processes form the molecular interface between the genome and the environment, contributing to the regulation of gene expression in health and disease. Investigation of epigenetic mechanisms is yielding exciting insights in many areas of medicine, and a large and rapidly growing literature describes epigenetics as central to many aspects of the pathophysiology of psychotic disorders. This article first discusses speculative points as to why the mechanisms of epigenetics may be satisfying explanatory mechanisms in the etiology of psychotic disorders, then details emerging experimental evidence of roles for the three types of epigenetic mechanisms in these illnesses, and finally discusses these mechanisms as potentially compelling areas of research for the development of future treatments.

Entities:  

Mesh:

Year:  2015        PMID: 25943315      PMCID: PMC5547575          DOI: 10.1097/HRP.0000000000000048

Source DB:  PubMed          Journal:  Harv Rev Psychiatry        ISSN: 1067-3229            Impact factor:   3.732


  95 in total

1.  Heterochromatin protein 1 is required for the normal expression of two heterochromatin genes in Drosophila.

Authors:  B Y Lu; P C Emtage; B J Duyf; A J Hilliker; J C Eissenberg
Journal:  Genetics       Date:  2000-06       Impact factor: 4.562

2.  Epigenetics and twins: three variations on the theme.

Authors:  Arturas Petronis
Journal:  Trends Genet       Date:  2006-05-11       Impact factor: 11.639

3.  Circuitry-based gene expression profiles in GABA cells of the trisynaptic pathway in schizophrenics versus bipolars.

Authors:  Francine M Benes; Benjamin Lim; David Matzilevich; Sivan Subburaju; John P Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-22       Impact factor: 11.205

4.  Combinatorial patterns of histone acetylations and methylations in the human genome.

Authors:  Zhibin Wang; Chongzhi Zang; Jeffrey A Rosenfeld; Dustin E Schones; Artem Barski; Suresh Cuddapah; Kairong Cui; Tae-Young Roh; Weiqun Peng; Michael Q Zhang; Keji Zhao
Journal:  Nat Genet       Date:  2008-06-15       Impact factor: 38.330

5.  Cytosine methylation in CTF and Sp1 recognition sites of an HSV tk promoter: effects on transcription in vivo and on factor binding in vitro.

Authors:  J Ben-Hattar; P Beard; J Jiricny
Journal:  Nucleic Acids Res       Date:  1989-12-25       Impact factor: 16.971

6.  Cytosine methylation does not affect binding of transcription factor Sp1.

Authors:  M A Harrington; P A Jones; M Imagawa; M Karin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

Review 7.  MicroRNA dysregulation in schizophrenia.

Authors:  Natalie J Beveridge; Murray J Cairns
Journal:  Neurobiol Dis       Date:  2011-12-21       Impact factor: 5.996

8.  MeCP2 in the nucleus accumbens contributes to neural and behavioral responses to psychostimulants.

Authors:  Jie V Deng; Ramona M Rodriguiz; Ashley N Hutchinson; Il-Hwan Kim; William C Wetsel; Anne E West
Journal:  Nat Neurosci       Date:  2010-08-15       Impact factor: 24.884

9.  The reelin and GAD67 promoters are activated by epigenetic drugs that facilitate the disruption of local repressor complexes.

Authors:  Marija Kundakovic; Ying Chen; Alessandro Guidotti; Dennis R Grayson
Journal:  Mol Pharmacol       Date:  2008-11-24       Impact factor: 4.436

10.  Genome-wide association study identifies five new schizophrenia loci.

Authors: 
Journal:  Nat Genet       Date:  2011-09-18       Impact factor: 38.330

View more
  1 in total

Review 1.  Epigenome Interactions with Patterned Neuronal Activity.

Authors:  Jillian Belgrad; R Douglas Fields
Journal:  Neuroscientist       Date:  2018-02-27       Impact factor: 7.519

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.